ed3f4bd4-8a9d-42dd-83c5-a8f634599706
Misago® - Self-expanding peripheral stent
Terumo is in every detail
Misago is a peripheral self-expanding stent system consisting of a rapid exchange delivery catheter and a pre-mounted stent made of nitinol.
Misago is intended for use in the treatment of stenotic or occlusive lesions in iliac or femoro-popliteal arteries to establish and maintain patency.
Characteristics
- Increased conformability within unique open-cell design1
- Optimized radial force to reduce thrombosis and neointima hyperplasia1,2
- Increased flexibility in severe bend situations1
- Precise deployment with simplified single-operator system3
- Proven performance in treating patients worldwide with peripheral artery disease (PAD)3,4,5
Read more
Read less
| Stent material | Nitinol alloy |
|---|
| Stent strut thickness | 0.185 mm |
|---|
| Delivery catheter structure | Rapid exchange with ergonomic grip |
|---|
| Guidewire compatibility | 0.035" (0.89 mm) |
|---|
| Minimum sheath size | 6 Fr / 2.0 mm |
|---|
| Usable length of catheter | 135 cm |
|---|
See the difference
Increased flexibility lowers the potential for stent fracture:1
- Open-cell structure: The continuous spine-free stent is designed to promote optimal blood flow and eliminate high-strain stress zones that can lead to fracture1
- In the JP-OSPREY clinical trial, 0% incidence of stent fracture per stent at 12 months post-procedure3
- Optimized radial force to reduce thrombosis and neointima hyperplasia2
Feel the difference
Responds to a patient’s natural anatomy with increased conformability6:
- Responsive in-vitro performance even in severe bend situations.1 In comparison to other self-expanding nitinol stents tested, Misago demonstrated high flexibility and durability in rigorous fatigue-testing simulations.
- No stent fractures recorded during:
- 40% compression test that simulated the response during thigh contraction
- 90° torsion test that simulated the rotation between supine and fetal position
- More flexible stents may be associated with improved patency7
- Precision deployment with 100% delivery success3
- Minimizes jumping, recoil or foreshortening with an easy-to-use thumbwheel system that allows for single operator deployment
- Enables exact stent placement with the pushability of a triaxial catheter design
Make a difference
Realize meaningful long-term outcomes in superficial femoral and popliteal arteries.8
Clinically proven results in difficult to treat lesions:
- In long calcified lesions (> 8 cm)9
90.3% Primary patency rate at 1 year - In popliteal lesions (p1-p3)10
91.5% Primary patency rate at 1 year
| 40 | 60 | 80 | 100 | 120 | 150 |
| 5 mm | SX-VXA0540LN | SX-VXA0560LN | SX-VXA0580LN | SX-VXA05X0LN | — | — |
|---|
| 6 mm | SX-VXA0640LN | SX-VXA0660LN | SX-VXA0680LN | SX-VXA06X0LN | SX-VXA06X2LN | SX-VXA06X5LN |
|---|
| 7 mm | SX-VXA0740LN | SX-VXA0760LN | SX-VXA0780LN | SX-VXA07X0LN | SX-VXA07X2LN | SX-VXA07X5LN |
|---|
| 8 mm | SX-VXA0840LN | SX-VXA0860LN | SX-VXA0880LN | SX-VXA08X0LN | — | — |
|---|
| 9 mm | SX-VXA0940LN | SX-VXA0960LN | — | — | — | — |
|---|
| 10 mm | SX-VXA1040LN | SX-VXA1060LN | — | — | — | — |
|---|
Please quote above item reference codes when placing an order
This Product is no longer available for sales.
This Product is no longer available for sales.
An Error Occured In Hayabusa SeeAlso: Object reference not set to an instance of an object.
1 Müller-Hülsbeck S, Schäfer PJ, Charalambous N, et al. Comparison of Second-Generation Stents for Application in the Superficial Femoral Artery: An In Vitro Evaluation Focusing on Stent Design. J Endovasc Ther. 2010;17(6):767-776.
2 Deloose K, et al. TVR Reduction in the SFA. EVTODAY. October, 2014;44-47.
3 Presented by Dr Yokoi at TCT 2014.
4 Presented by Dr Ruef at CIRSE 2014.
5 Presented by Dr Müller-Hülsbeck at CIRSE 2014.
6 Compared to six other stents with regard to the appearance of fracture. Müller-Hülsbeck S, Schäfer PJ, Charalambous N, et al. Comparison of Second-Generation Stents for Application in the Superficial Femoral Artery: An In Vitro Evaluation Focusing on Stent Design. J Endovasc Ther. 2010;17(6):767-776.
7 Smouse, R. Achieving Long Term SFA Treatment Success: Stent Design or Patient Selection. International Symposium on Endovascular Therapy, January 2014.
8 I. Kralj et al. Vasa, 2012; 42:313.
9 Results from e-Misago registry - n = 434.
10 Results from e-Misago registry - n = 329.
Did you not find the product you were looking for?
